These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Neurobiology and pharmacotherapy of social phobia]. Aouizerate B; Martin-Guehl C; Tignol J Encephale; 2004; 30(4):301-13. PubMed ID: 15538306 [TBL] [Abstract][Full Text] [Related]
4. New uses for antidepressants: social phobia. Keck PE; McElroy SL J Clin Psychiatry; 1997; 58 Suppl 14():32-6; discussion 37-8. PubMed ID: 9418744 [TBL] [Abstract][Full Text] [Related]
5. Antidepressants in social anxiety disorder. Nardi AE Arq Neuropsiquiatr; 2001 Sep; 59(3-A):637-42. PubMed ID: 11588653 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Lotufo-Neto F; Trivedi M; Thase ME Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483 [TBL] [Abstract][Full Text] [Related]
7. The role of drug therapy in social phobia. Lydiard RB J Affect Disord; 1998 Sep; 50 Suppl 1():S35-9. PubMed ID: 9851577 [TBL] [Abstract][Full Text] [Related]
8. Moclobemide. An update of its pharmacological properties and therapeutic use. Fulton B; Benfield P Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133 [TBL] [Abstract][Full Text] [Related]
9. The pharmacotherapy of social phobia. Pollack MH; Gould RA Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():71-5. PubMed ID: 8923113 [TBL] [Abstract][Full Text] [Related]
10. A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). Versiani M World J Biol Psychiatry; 2000 Jan; 1(1):27-33. PubMed ID: 12607230 [TBL] [Abstract][Full Text] [Related]
11. Moclobemide: therapeutic use and clinical studies. Bonnet U CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913 [TBL] [Abstract][Full Text] [Related]
12. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Liebowitz MR; Hollander E; Schneier F; Campeas R; Welkowitz L; Hatterer J; Fallon B Acta Psychiatr Scand Suppl; 1990; 360():29-34. PubMed ID: 2248064 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for social phobia. Stein DJ; Ipser JC; Balkom AJ Cochrane Database Syst Rev; 2004 Oct; (4):CD001206. PubMed ID: 15495010 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings. Atmaca M; Kuloglu M; Tezcan E; Unal A Hum Psychopharmacol; 2002 Dec; 17(8):401-5. PubMed ID: 12457375 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of social phobia. Davidson JR Acta Psychiatr Scand Suppl; 2003; (417):65-71. PubMed ID: 12950437 [TBL] [Abstract][Full Text] [Related]
16. Social phobia: a pharmacologic treatment overview. Jefferson JW J Clin Psychiatry; 1995; 56 Suppl 5():18-24. PubMed ID: 7782272 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Versiani M; Nardi AE; Mundim FD; Alves AB; Liebowitz MR; Amrein R Br J Psychiatry; 1992 Sep; 161():353-60. PubMed ID: 1393304 [TBL] [Abstract][Full Text] [Related]
18. Recent developments in the psychopharmacology of social phobia. Den Boer JA; van Vliet IM; Westenberg HG Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):309-16. PubMed ID: 7772614 [TBL] [Abstract][Full Text] [Related]
19. Medication treatments for panic disorder and social phobia. Stein MB Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095 [TBL] [Abstract][Full Text] [Related]